WC, W., KF, E., P, K., M, H., ME, M., TI, C., & J, N. (2026). Effectiveness and Safety of Apixaban Initiation Following Newly-Diagnosed Atrial Fibrillation in Patients With Kidney Failure on Hemodialysis. American journal of kidney diseases : the official journal of the National Kidney Foundation, 87(3), 313. https://doi.org/10.1053/j.ajkd.2025.10.009
Chicago Style (17th ed.) CitationWC, Winkelmayer, Erickson KF, Khairallah P, He M, Montez-Rath ME, Chang TI, and Niu J. "Effectiveness and Safety of Apixaban Initiation Following Newly-Diagnosed Atrial Fibrillation in Patients With Kidney Failure on Hemodialysis." American Journal of Kidney Diseases : The Official Journal of the National Kidney Foundation 87, no. 3 (2026): 313. https://doi.org/10.1053/j.ajkd.2025.10.009.
MLA (9th ed.) CitationWC, Winkelmayer, et al. "Effectiveness and Safety of Apixaban Initiation Following Newly-Diagnosed Atrial Fibrillation in Patients With Kidney Failure on Hemodialysis." American Journal of Kidney Diseases : The Official Journal of the National Kidney Foundation, vol. 87, no. 3, 2026, p. 313, https://doi.org/10.1053/j.ajkd.2025.10.009.